Skip to content

COVID-19 Innovation Conference - Worldwide Online Investment Event

to
948 people attended
Press here to view detailed AGENDA.

Press here to view the companies fighting COVID-19

As the COVID-19 pandemic spreads across the world, many start-ups, established companies, innovators, governmental laboratories and academic institutions are searching for solutions to end the pandemic. Their goal is to find quick solutions to treat patients and support healthcare givers, to prevent contaminations now and in the future and to build and adapt the current hospital settings. Some of them have already diverted their strategy towards a fast and practical aid, others anticipate future needs.

Cukierman & Co. Life Sciences’ mission for this event is to present emerging companies and technologies that are working on any related solutions to help fighting the coronavirus now, its potential next generation mutations, and preventing it from hurting us in the future. We want to accelerate innovations and market reach through shared technological breakthroughs and the future pandemics to come.

Hundreds of leading global investors & strategic players are expected to participate to get a taste of the most promising and advanced solutions against the COVID-19 pandemic and for future prevention needs. You will be able to present your technology in the plenary online session and explore equity funding and/or strategic partnering opportunities.

The companies presenting at the 2020 COVID-19 Innovation Conference are leading start-ups that have deployed or are applying their technology to fight the pandemia in the fields of Vaccines, Medical Devices, Biotechnology, Pharmaceuticals, Diagnostics, Robotics and Digital Health.

The companies taking part in the 2020 COVID-19 Innovation Conference are leading start-ups in the fields of Vaccines, Medical Devices, Biotechnology, Pharmaceuticals, Diagnostics, Robotics and Digital Health

As part of the initiative, Cukierman & Co. Life Sciences and GoforIsrael are giving participants the opportunity to donate USD 100 (or more) to the Technion COVID-19 Emergency Fund (press for info) to contribute to the prevention and treatment research efforts. Donate here.

REGISTRATION INSTRUCTIONS:
1. Click on tickets
2. Create a Hopin account
3. Choose type of ticket & checkout
4. Add to your calendar!

LOGIN TO EVENT INSTRUCTIONS:
1. Go on event website (this one)
2. If you are not logged in already, press the login button on the top right corner
3. Go to My Account
4. Click on the COVID-19 INNOVATION CONFERENCE - Worldwide Online Investment Event
5. And you are in!

Proudly Supported By

Schedule

· Stage
Opening & Welcoming Remarks
Laurent Choppe Edouard Cukierman
· Stage
Panel Discussion: Innovation fighting COVID-19 health threats: sharing experiences, identifying challenges & finding solutions
Pr. Dror Mevorach Pr. Frédéric  Tangy Dr. Eyal  Zimlichman Laurent Choppe Yi Ning Huiqing Ge
· Stage
Keynote Speaker
Dr. Ami Appelbaum
· Stage
COVID-19 Company Presentations
Lucien Vouillamoz Cliff Ansel Pr. Philippe Halfon Danny Lustiger Shai Novik Roy Hirsch Charles Carignan Amir Nardimon Tomer Lark Asher Polani Ronen Sarusi Denis Barritault Dr. Amos Danielli Frederic Hemmeler Avital Frenkel Tal Wenderow Dr. Xuefeng Yu
· Stage
Closing Remarks
Pr. Alon Wolf
· Stage
Opening & Welcoming Remarks
Laurent Choppe Edouard Cukierman
· Stage
Panel Discussion: Innovation fighting COVID-19 health threats: sharing experiences, identifying challenges & finding solutions
Pr. Dror Mevorach Pr. Frédéric  Tangy Shy Zyman Yi Ning Huiqing Ge Dr. Xuefeng Yu
· Stage
Keynote Speaker
Dr. Ami Appelbaum
· Stage
COVID -19 Company Presentations
Lucien Vouillamoz Cliff Ansel Pr. Philippe Halfon Danny Lustiger Shai Novik Roy Hirsch Charles Carignan Amir Nardimon Tomer Lark Asher Polani Ronen Sarusi Denis Barritault Dr. Amos Danielli Frederic Hemmeler Avital Frenkel Tal Wenderow Dr. Xuefeng Yu
· Stage
Closing Remarks
Pr. Alon Wolf

Speakers

Pr. Frédéric Tangy

PhD, Dr.Sc. - Virology Director of Research at CNRS; Head of Vaccine Innovation Lab - Institut Pasteur (Paris, France)

Pr. Dror Mevorach

Prof. Dror Mevorach, M.D., Chief Scientific & Medical Officer – Enlivex (Ness Ziona, Israel)

Shai Novik

Executive Chairman, Enlivex

Danny Lustiger

Co-founder & CEO, MedCu

Pr. Philippe Halfon

(MD, PhD), President & Founder, Genoscience Pharma

Cliff Ansel

CEO, Respinova

Lucien Vouillamoz

CEO, Preci Health

Shy Zyman

Partner, Cukierman & Co. Life Sciences

Laurent Choppe

Managing Partner, Cukierman & Co. Life Sciences

Dr. Ami Appelbaum

Chief Scientist, Ministry of Economy and Industry & Chairman, Israel Innovation Authority

Roy Hirsch

Advisor, Sonovia

Charles Carignan

CEO, SoniVie

Yi Ning

(MD, Dr.Sc., MPH), VP & CSO, Meinian OneHealth Group & Executive Director, Peking University Meinian Public Health Resea

Amir Nardimon

Founder & CEO, Seamless Vision

Huiqing Ge

(MD) Director of Respiratory Care - Zhejiang University, Sir Run Run Shaw hospital (Hangzhou, China)

Tomer Lark

CEO, Serenno Medical

Asher Polani

CEO, ContinUse Biometrics

Dr. Xuefeng Yu

(PhD), Chairman and CEO at CanSino Biologics (Tianjin, China) (evening session)

Ronen Sarusi

Co-founder & CEO, Nanosono

Denis Barritault

President, OTR3

Edouard Cukierman

Chairman, Cukierman & Co. Investment House

Pr. Alon Wolf

(PhD) VP for External Relations & Resource Development, Professor of Mechanical and Biomedical Engineering, Technion Isr

Dr. Amos Danielli

CEO, MagBiosense

Frederic Hemmeler

CEO, Aero41

Avital Frenkel

Researcher, LIFT (Technion)

Tal Wenderow

Founder & CEO, Vocalis Health

Dr. Eyal Zimlichman

(MD, MSc) Deputy General Director, Chief Medical Officer and Chief Innovation Officer – Sheba Hospital (Tel Hashomer, Is

The event is over

Hosted by

Cukierman & Co. Life Sciences and GoforIsrael

Share on

Booths

Technion COVID-19 Emergency Fund - DONATE

Technion Researchers on the Frontline in the Fight against COVID-19 Technion scientists mobilized in the worldwide effort to find solutions for the current global health crisis.

Aero41, Delta Drone Group

High precision AI-driven disinfection flying robot

Causaly

Causaly AI is the only biomedical search tool that allows researchers to 'read' the entire body of published scientific literature, and find answers to questions in seconds that otherwise take weeks or months in research time.

Cukierman & Co. Life Sciences

Cukierman & Co. Life Sciences (CLS) provides services to companies across healthcare and are mandated by biotechnology, pharmaceuticals, diagnostics, medical devices and digital health companies. Established in 2006 as the Life Sciences arm of Cukierman & Co. Investment House, CLS offers investment banking services to private and public companies at different stages of their development.